RCKT FY 2021 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$572M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$167M

Net Income

-$169M

EPS (Diluted)

$-2.68

Cash Flow

Operating Cash Flow

-$121M

Free Cash Flow

-$129M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$497M

Total Liabilities

$42M

Stockholders' Equity

$455M

Cash & Equivalents

$233M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$1M	+100.0%
Operating Income	-$167M	-$136M	-23.0%
Net Income	-$169M	-$147M	-15.3%